![Lena Jendeberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lena Jendeberg
Directeur/Membre du Conseil chez
ATTANA AB
Profil
Dr. Lena Jendeberg is on the Board of Directors at Attana AB. Dr. Jendeberg was previously employed as a Vice President-Development by Modus Therapeutics AB. She received her doctorate degree from Royal Institute of Technology.
Postes actifs de Lena Jendeberg
| Sociétés | Poste | Début |
|---|---|---|
| ATTANA AB | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Lena Jendeberg
| Sociétés | Poste | Fin |
|---|---|---|
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Corporate Officer/Principal | - |
Formation de Lena Jendeberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Attana AB
 Attana AB Medical/Nursing ServicesHealth Services Develops biosensors for the pharmaceutical, diagnostic, and academic societies | Health Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
